Urine Proteome of Surgical Patients and Healthy Volunteers

Completed

Conditions studied: Renal Cell Cancer

In brief

The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.

Key facts

Study ID

NCT01538823

Run by

Washington University School of Medicine

People needed

664

Starts

2012-02-01

Expected to finish

2016-07-01

Last updated by the study team

2019-01-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years and older
• Planned procedure with presumptive diagnosis of RCC, bladder or prostate cancer OR control patient undergoing non-urological surgery OR normal healthy volunteer OR post surgical patient with a diagnosis of RCC and under surveillance for reoccurrence of RCC or treatment of metastatic RCC
• Signed, informed consent

You may not qualify if…

• Patients on dialysis

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.